-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O1.6 905. Outcomes Research – Lymphoid Malignancies: Outcomes Research in Myeloma: What's New?

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical Research
Sunday, December 10, 2023: 12:00 PM-1:30 PM
Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)
Moderators:
Nishi Shah, MBBS, MPH, Albert Einstein College of Medicine, Montefiore Medical Center and Ghulam Rehman Mohyuddin, MD,
Disclosures:
No relevant conflicts of interest to declare.
In this oral session, pertinent outcomes research and some real-world data is discussed in myeloma, as well as some COVID research pertaining to hematological malignancies.
12:00 PM

Alissa Visram, MD, MPH1, Kelvin KW Chan, MD, PhD2*, Hsien Seow3*, Gregory Pond4*, Ana Gayowsky5*, Arleigh McCurdy, MD, BSc6, Irwindeep Sandhu7, Christopher P. Venner, MD8, Guido Lancman, MD, MSc9, Amaris Balitsky, MD10, Robert Bruins11*, Shaji Kunnathu Kumar, MD12, Rafael Fonseca, MD13 and Hira Mian, MD10

1Division of Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
2Sunnybrook Health Sciences Centre, Toronto, Canada
3Department of Oncology, McMaster University, Hamilton, ON, Canada
4Escarpment Cancer Research Institute, McMaster University, Hamilton, ON, Canada
5Institute for Clinical Evaluative Sciences, McMaster University, Hamilton, ON, Canada
6The Ottawa Hospital, Ottawa, ON, Canada
7Cross Cancer Institute, Edmonton, AB, Canada
8BC Cancer – Vancouver Centre, University of British Columbia, Vancouver, BC, Canada
9University of Toronto, Toronto, ON, Canada
10McMaster University, Hamilton, ON, Canada
11Eli Lilly Canada Inc., Toronto, ON, Canada
12Division of Hematology, Mayo Clinic, Rochester, MN
13Mayo Clinic, Phoenix, AZ

12:15 PM

Hira Mian, MD1,2, Jennifer S. Harper, PhD3*, Hoa H. Le, PhD4*, Alex Z. Fu3,5*, Saurabh N. Patel, MD6*, Xinke Zhang, PhD4* and Rafael Fonseca, MD7

1Juravinski Cancer Center, Hamilton, ON, Canada
2McMaster University, Hamilton, ON, Canada
3Janssen Scientific Affairs, LLC, Titusville, NJ
4Janssen Scientific Affairs, LLC, Horsham, PA
5Georgetown University Medical Center, Washington, DC
6Johnson & Johnson, Horsham, PA
7Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ

12:30 PM

Doris K. Hansen, MD1,2*, Santosh Gautam3*, Marie-Hélène Lafeuille4*, Carmine Rossi4*, Bronwyn Moore, BA4*, Anabelle Tardif-Samson4*, Philippe Thompson-Leduc4*, Alex Z. Fu3*, Annelore Cortoos3*, Shuchita Kaila3* and Rafael Fonseca, MD5

1H. Lee Moffitt Cancer Center & Research Institute, Tampa
2H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Janssen Scientific Affairs LLC, Horsham
4Analysis Group, Inc., Montréal, Canada
5Mayo Clinic in Arizona, Phoenix

12:45 PM

Fieke W Hoff, MD, PhD1, Rahul Banerjee, MD2, Adeel Khan, MD3*, Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA4*, Xiaoliang (Wendy) Wang, PhD5, James Roose, MS6*, Larry D. Anderson Jr., MD, PhD7, Andrew J. Cowan, MD8, Vincent Rajkumar, MD9* and Gurbakhash Kaur, MD, MA3

1UT Southwestern Medical Center, Dallas, TX
2University of Washington, Seattle, WA
3Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX
4Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
5Flatiron Health, INC., New York, NY
6Flatiron Health, New York, NY
7Hematologic Malignancies and Cellular Therapy, UT Southwestern Medical Center, Dallas, TX
8Fred Hutchinson Cancer Center, Seattle, WA
9Mayo Clinic, Rochester, MN

1:00 PM

Meera Mohan, MD1, Nishi Shah, MBBS, MPH2, Danny Luan, MD, MPH3, Jorge Monge4*, Mark Forsberg, MD5*, Vineel Bhatlapenumarthi, MD6*, Metodi Balev, MD7*, Anannya Patwari, MD8*, Heloise Cheruvalath, BS9*, Divaya Bhutani, MD10, Sharmilan Thanendrarajan, MD11*, Binod Dhakal, MD12*, Maurizio Zangari, MD11, Samer Al Hadidi, MD, MSc11, Dennis L Cooper, MD13*, Suzanne Lentzsch, MD, PhD14*, Frits van Rhee, MD, PhD11, Anita D'Souza, MD, MS15, Aniko Szabo, PhD16*, Carolina Schinke, MD17 and Rajshekhar Chakraborty18*

1BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
3Newyork-Presbyterian Hospital/Weill Cornell Medical College, New York, NY
4Weill Cornell Medicine, New York
5Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
6Department of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI
7Columbia University Irving Medical Center, New York
8Medical College of Wisconsin, Milwaukee
9Medical College of Wisconsin Medical School, Milwaukee
10Columbia University, College of Physicians and Surgeons, New York, NY
11Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
12Medical College of Wisconsin, Wauwatosa, WI
13Montefiore Medical Center, New York
14Columbia University Irving Medical Center, New York Presbyterian, New York, NY
15The Medical College of Wisconsin Inc, Milwaukee, WI
16Medical College of Wisconsin, Milwaukee, WI
17Myeloma Institute, Little Rock, AR
18Columbia University Irving Medical Center, New York, NY

1:15 PM

Quincy Hofsink1,2,3*, Sabine Haggenburg1,2,3*, Birgit I. Lissenberg-Witte4*, Abraham Goorhuis5*, Mette D. Hazenberg1,2,3,6*, Caroline E. Rutten2*, Sonja Zweegman, MD, PhD7, Jeanet Kemmeren8*, Nicolette F. de Keizer9*, Peter C. Huijgens10*, Avinash G. Dinmohamed10*, Susan van den Hof8*, Brechje de Gier8*, Mirjam Knol8*, Susan Hahné8*, Jarom Heijmans2,11* and Inger S. Nijhof, MD, PhD7,12*

1Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, Netherlands
2Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
3Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
4Department of Epidemiology and Data Science, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands
5Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
6Department of Hematopoiesis, Sanquin Research, Amsterdam, Netherlands
7Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands
8Center for Epidemiology and Surveillance of Infectious Diseases, National Institute for Public Health and the Environment, Bilthoven, Netherlands
9National Intensive Care Evaluation (NICE) Foundation, Amsterdam, Netherlands
10Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands
11Department of General Internal Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
12Department of Internal Medicine-Hematology, St. Antonius Hospital, Nieuwegein, Netherlands

*signifies non-member of ASH